Novartis AG (ADR) (NVS) — I last featured NVS stock as the Trade of the Day on Oct. 1, recommending traders sell shares short at $95 with a downside target of $85. At the time, I noted Novartis’ pharmaceutical …
Investor Place · BySam Collins · 11/24/2015
Short NVS Stock
Novartis AG (NYSE:NVS) was downgraded by investment analysts at Vontobel to a “hold” rating in a report released on Monday, Analyst Ratings reports. Novartis AG (NYSE:NVS) opened at 86.40 on Monday. The firm has a market cap of …
Watch List News · 11/25/2015
Novartis AG
NVS) saw unusually-strong trading volume on Friday , Analyst Ratings Net reports. Approximately 1,176,223 shares were traded during mid-day trading, a decline of 38% from the previous session’s volume of 1,898 …
Ticker Report · 1 day ago
Novartis AG
More from Bing News
In addition to specific proprietary factors, Trade-Ideas identified Novartis as such a stock due to the following factors: NVS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $144.2 million. NVS traded ...
The Street · 11/17/2015
Recently, Novartis filed for approval of a biosimilar to Neulasta ... their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early in-the-know …
The Motley Fool · 1 day ago
Healthcare Dividend Stock
while Ophthalmic Pharmaceuticals is facing the threat of increased generic competition in the U.S. Novartis currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the health care sector include Novo Nordisk A/S (NVO - Analyst Report), Eli ...
ZACKS · 11/25/2015
Cardiovascular Drug
However, Amgen itself is facing biosimilar competition in the U.S. Zarxio, the first FDA-approved biosimilar, was launched by Novartis AG's NVS generic arm ... Amgen is a Zacks Rank #3 (Hold) stock. A better-ranked …
NASDAQ · 11/27/2015
FDA Approval
Novartis wined and dined doctors at high-end restaurants ... cause a liquidity strain for Valeant and send the stock tumbling. With $31 billion in debt at junk levels, the company will be hard-pressed to find new investors …
Seeking Alpha · 11/27/2015
Warne is also positive on health care and is bullish on Novartis (NVS), though that stock is down nearly 9% since a year ago. “It has the best new drug pipeline,” she said. “It's also diversified because it has generic drugs and it has eye care.
Yahoo Finance · 11/18/2015
outpacing not only inflation but also overall growth in health care spending. Valeant shares closed down 0.5% on the stock market today. GlaxoSmithKline rose 0.8%, and Novartis dipped 0.5%.
Investors Business Daily · ByJames Detar · 11/25/2015
Drug Prices


Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland, ranking number one in sa…
Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland, ranking number one in sales among the world-wide industry in 2013. In July 2015, Novartis had a market-cap of around $280 billion making it the largest healthcare company by this metric.
Data from: Wikipedia